Total Positions
14
Quarter
2025 Q4
Top Holding
GLD (64.5%)
Top 10 Concentration
99.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-14 of 14
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GLD
SPDR GOLD TR
|
ETF | 64.50% | 11.33% |
#1
1
Prev: #2
|
10.0 | -322 | -4.4% |
P
S
|
6,964 | $2,759,901 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BRK/B
BERKSHIRE HATHA...
|
Financial Services | 8.34% | 1.43% |
#2
1
Prev: #3
|
5.4 | 59 | 9.1% |
P
S
|
710 | $356,771 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 6.83% | — |
#3
Prev: #—
|
4.7 | 8,919 | no change |
NEW
|
8,919 | $292,194 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNMD
MIND MEDICINE M...
|
Healthcare | 4.91% | 1.39% |
#4
Prev: #4
|
2.1 | -11,323 | -41.9% |
P
S
|
15,688 | $210,058 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KYTX
KYVERNA THERAPE...
|
Healthcare | 4.12% | 0.60% |
#5
3
Prev: #8
|
1.7 | -4,208 | -18.3% |
P
S
|
18,773 | $176,468 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 3.70% | 0.82% |
#6
Prev: #6
|
1.6 | -24,008 | -44.9% |
P
S
|
29,495 | $158,386 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LXEO
LEXEO THERAPEUT...
|
Healthcare | 3.24% | 0.50% |
#7
2
Prev: #9
|
1.4 | -3,389 | -19.6% |
P
S
|
13,943 | $138,453 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 1.45% | — |
#8
Prev: #—
|
2.6 | 15,557 | no change |
NEW
|
15,557 | $62,227 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 1.36% | 0.12% |
#9
1
Prev: #10
|
2.8 | 12,060 | 73.6% |
P
S
|
28,453 | $58,328 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SABS
SAB BIOTHERAPEU...
|
Healthcare | 0.92% | 0.10% |
#10
1
Prev: #11
|
0.4 | -408 | -3.7% |
P
S
|
10,527 | $39,371 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 0.63% | 0.08% |
#11
1
Prev: #12
|
0.3 | no change | no change |
P
S
|
18,403 | $27,053 | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 0.00% | 81.70% |
Sold All 😨
(Was: #1) |
0.3 | -1,986,818 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.00% | 1.17% |
Sold All 😨
(Was: #5) |
0.3 | -13,097 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 0.00% | 0.76% |
Sold All 😨
(Was: #7) |
0.3 | -10,941 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-14 of 14 holdings